Skip to main navigation
Skip to search
Skip to main content
Northern Arizona University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Present and future therapeutic strategies for melioidosis and glanders
D. Mark Estes
, Steven W. Dow
, Herbert P. Schweizer
, Alfredo G. Torres
Research output
:
Contribution to journal
›
Review article
›
peer-review
93
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Present and future therapeutic strategies for melioidosis and glanders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Malleus
100%
Glanders
100%
Melioidosis
100%
Pseudomallei
100%
Therapeutic Strategies
100%
Future Therapeutics
100%
Burkholderia Pseudomallei
50%
Public Health
50%
Diabetic
50%
Bioterrorism Agent
50%
Causative Agents
50%
Genome Sequencing
50%
Burkholderia Mallei
50%
High Mortality Rate
50%
Therapeutic Use
50%
Severe Infection
50%
Modern History
50%
Antibiotic Therapy
50%
Novel Therapeutics
50%
Opportunistic Infections
50%
Gram-negative Pathogens
50%
New Therapeutics
50%
Growing Population
50%
Mandatory Vaccines
50%
Antibiotic Discovery
50%
Malicious Use
50%
Destructive Impact
50%
Prophylactic Use
50%
Target Identification
50%
Medicine and Dentistry
Melioidosis
100%
Pathogen
100%
Glanders
100%
Disease
50%
Malleus
50%
Burkholderia pseudomallei
25%
Public Health
25%
Infection
25%
Mortality Rate
25%
Diabetes Mellitus
25%
Drug Therapy
25%
Antibiotic Therapy
25%
Burkholderia mallei
25%
Antiinfective Agent
25%
Opportunistic Infection
25%
Target Identification
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infectious Agent
100%
Glanders
100%
Melioidosis
100%
Disease
50%
Burkholderia pseudomallei
25%
Infection
25%
Mortality Rate
25%
Antiinfective Agent
25%
Antibiotic Therapy
25%
Diabetes Mellitus
25%
Burkholderia mallei
25%
Drug Discovery
25%
Therapeutic Use
25%
Target Identification
25%
Opportunistic Infection
25%
Immunology and Microbiology
Infectious Agent
100%
Burkholderia pseudomallei
25%
Mortality Rate
25%
Burkholderia mallei
25%
Vaccine Efficacy
25%
Opportunistic Infection
25%